Saliva as an Emerging Biofluid for Clinical Diagnosis and Applications of MEMS/NEMS in Salivary Diagnostics

Nanobiomaterials in Clinical Dentistry

Volumn , Issue , 2012, Pages 453-473

  Punyadeera, Chamindie ^a,b   Slowey, Paul D ^c  

^a Australian Institute for Bioengineering and Nanotechnology   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c Oasis Diagnostics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSIS;

CLINICAL DIAGNOSIS; MEMS/NEMS;

BODY FLUIDS;

EID: 84906798142     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4557-3127-5.00022-2     Document Type: Chapter

References (106)

1. Marmud D. Saliva as a diagnostic fluid second now to blood?. BMJ 1992, 305:25.
2. S. Hu, D.T. Wong, M. Arellano, P. Boontheing, J. Wang, H. Zhou, et al., Salivary Protein Biomarkers for Human Oral Cancer, Clin Cancer Research 14 (19) (2008) 6246-6252.
3. Rao P.V., Reddy A.P., Lu X., Dasari S., Krishnaprasad A., Biggs E, et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J. Proteome Res. 2009, 8(1):239-245.
4. Pfaffe T., Cooper-White J., Beyerlein P., Kostner K., Punyadeera C., et al. Diagnostic potential of saliva: current state and future applications. Clin. Chem. 2011, 57(5):675-687.
5. Bouwman F., et al. 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting. BMC Med. Genomics 2011, 4(1):24.
6. Yan W., et al. Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin. Appl. 2009, 3(1):116-134.
7. Bandhakavi S., et al. A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J. Proteome Res. 2009, 8(12):5590-5600.
8. Loo J.A., et al. Comparative human salivary and plasma proteomes. J. Dent. Res. 2010, 89(10):1016-1023.
9. Punyadeera, G.Dimeski, K.Kostner, P.Beyerlein, J.Cooper-White C., et al. One-step homogeneous C-reactive protein assay for saliva. J. Immunol. Methods 2011.
10. Christodoulides, M.Sanghamitra, M.S.Craig, L.M.Chris, N.Floriano, P.D.Priya N., et al. Application of microchip assay system for the measurement of C-reactive protein in human saliva. Lab Chip 2005, 5(3):261-269.
11. Ridker P.M. C-reactive protein, inflammation, and cardiovascular disease: clinical update. Tex. Heart Inst. J. 2005, 32(3):384-386.
12. Ridker P.M., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 2008, 359(21):2195-2207.
13. Arima H., et al. High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler Thromb Vasc. Biol. 2008, 28(7):1385-1391.
14. Miller C.S., et al. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J. Am. Dent. Assoc. 2006, 137(3):322-329.
15. D.A. Ovchinnikov, M.A. Cooper, P. Pandit, W.B. Coman, J. Cooper-White, P. Keith, et al., Tumour-suppressor gene promoter hypermethylation in saliva of head and neck cancer patients. J. Trans. Oncol., September 2012.
16. Shpitzer T., et al. A comprehensive salivary analysis for oral cancer diagnosis. J. Cancer Res. Clin. Oncol. 2007, 133(9):613-617.
17. D.T. Wong, Oral cancer and saliva diagnostics, in: National Oral Health Conference, 2007, Denver, CO.
18. Hu S., et al. Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res. 2010, 62(11):1633-1638.
19. L. Zhang, J.J. Farrell, H. Zhou, D. Elashoff, D. Akin, N.-H. Park, et al., Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer, Gastroenterology, (138) (2010) 949-957.
20. Streckfus C.F., et al. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin. Cancer Res. 2000, 6(6):2363-2370.
21. Streckfus C.F., et al. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest. 2008, 26(2):159-167.
22. Castagnola M., Picciotti P.M., Messana I., Fanali C., Fiorita A., Cabras T., et al. Potential applications of human saliva as diagnostic fluid. Acta Otorhinolaryngol Ital. 2011, 31(6):347-357.
23. Topkas E., et al. Evaluation of saliva collection devices for the analysis of proteins. Clin. Chim. Acta 2012, 413(13-14):1066-1070.
24. Chicharro J.L., et al. Saliva composition and exercise. Sports Med. 1998, 26(1):17-27.
25. Anzano M.A., Lamb A.J., Olson J.A. Impaired salivary gland secretory function following the induction of rapid, synchronous vitamin A deficiency in rats. J. Nutr. 1981, 111(3):496-504.
26. Walsh N.P., et al. Saliva flow rate, total protein concentration and osmolality as potential markers of whole body hydration status during progressive acute dehydration in humans. Arch. Oral Biol. 2004, 49(2):149-154.
27. Ferguson D.B. Current diagnostic uses of saliva. J. Dent. Res. 1987, 66(2):420-424.
28. Dawes C. Salivary flow patterns and the health of hard and soft oral tissues. J. Am. Dent. Assoc. 2008, 139(Suppl. 2):18S-24S.
29. Oppenheim F.G., et al. Salivary proteome and its genetic polymorphisms. Ann. N.Y. Acad. Sci. 2007, 1098:22-50.
30. Mandel I.D., et al. Salivary studies in cystic fibrosis. Am. J. Dis. Child. 1967, 113(4):431-438.
31. Mandel I.D. Relation of saliva and plaque to caries. J. Dent. Res. 1974, 53(2):246-266.
32. Hansen A.M., Garde A.H., Persson R. Measurement of salivary cortisol-effects of replacing polyester with cotton and switching antibody. Scand. J. Clin. Lab. Invest. 2008, 68(8):826-829.
33. Hansen A.M., Garde A.H., Persson R. Sources of biological and methodological variation in salivary cortisol and their impact on measurement among healthy adults: a review. Scand. J. Clin. Lab. Invest. 2008, 68(6):448-458.
34. Helmerhorst E.J., Oppenheim F.G. Saliva: a dynamic proteome. J. Dent. Res. 2007, 86(8):680-693.
35. Caporossi L., Santoro A., Papaleo B. Saliva as an analytical matrix: state of the art and application for biomonitoring. Biomarkers 2010, 15(6):475-487.
36. Groschl M. Current status of salivary hormone analysis. Clin. Chem. 2008, 54(11):1759-1769.
37. Groschl M. The physiological role of hormones in saliva. Bioessays 2009, 31(8):843-852.
38. Granger D.A., et al. Integration of salivary biomarkers into developmental and behaviorally-oriented research: problems and solutions for collecting specimens. Phys. Behav. 2007, 92(4):583-590.
39. Megson E., et al. C-reactive protein in gingival crevicular fluid may be indicative of systemic inflammation. J. Clin. Periodontol. 2010, 37(9):797-804.
40. Tanaka Y., et al. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36(2):220-224.
41. Yamada S., et al. Saliva level of free 3-methoxy-4-hydroxyphenylglycol (MHPG) as a biological index of anxiety disorders. Psychiatry Res. 2000, 93(3):217-223.
42. Chang W.-I., et al. MUC1 expression in the oral mucosal epithelial cells of the elderly. Arch. Oral Biol. 2011, 56(9):885-890.
43. Ambatipudi K.S., et al. Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J. Proteome Res. 2009, 8(11):5093-5102.
44. Giltay E.J., et al. Salivary testosterone: associations with depression, anxiety disorders, and antidepressant use in a large cohort study. J. Psychosomatic. Res. 2012, 72(3):205-213.
45. Paclt I., et al. Circadian rhythms of saliva melatonin in ADHD, anxious and normal children. Neuro Endocrinol. Lett. 2011, 32(6):790-798.
46. Novakova M., et al. Salivary melatonin rhythm as a marker of the circadian system in healthy children and those with attention-deficit/hyperactivity disorder. Chronobiol. Int. 2011, 28(7):630-637.
47. Streckfus C.F., Arreola D., Edwards C., Bigler L. Salivary protein profiles among HER2/neu-receptor-positive and -negative breast cancer patients: support for using salivary protein profiles for modeling breast cancer progression. J. Oncol. 2012, 2012:9.
48. Punyani S., Sathawane R. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma. Clin. Oral Invest. 2012, 1-8.
49. Li X., Yang T., Lin J. Spectral analysis of human saliva for detection of lung cancer using surface-enhanced Raman spectroscopy. J. Biomed. Opt. 2012, 17:3.
50. Jarai T., et al. Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma. Pathol. Oncol. Res. 2012, 18(3):623-628.
51. L. Zhang, J.J. Farrell, H. Zhou, D. Elashoff, D. Akin, N.-H. Park, et al., Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer, Gastroenterology 38 (2010) 949-957.
52. Shiiki N., et al. Association between saliva PSA and serum PSA in conditions with prostate adenocarcinoma. Biomarkers 2011, 16(6):498-503.
53. Dyckhoff G., et al. Carbohydrate antigen 19-9 in saliva. Otolaryngol. Head Neck Surgery 2011, 145(5):772-777.
54. Yuan J., Dunn P., Martinus R.D. Detection of Hsp60 in saliva and serum from type 2 diabetic and non-diabetic control subjects. Cell Stress Chaperones 2011, 16(6):689-693.
55. Vasconcelos A.C.U., et al. Comparative study of the concentration of salivary and blood glucose in type 2 diabetic patients. J. Oral Sci. 2010, 52(2):293-298.
56. Costa P.P., et al. Salivary interleukin-6, matrix metalloproteinase-8, and osteoprotegerin in patients with periodontitis and diabetes. J. Periodontol. 2009, 81(3):384-391.
57. Thompson T., et al. Copper levels in buccal cells of vineyard workers engaged in various activities. Ann. Occup. Hyg. 2012, 56(3):305-314.
58. Wong Y.F., Mao L.E., Tam K.R., Panesar P.P., Neale N.S., Chang E., et al. Salivary oestradiol and progesterone after in vitro fertilization and embryo transfer using different luteal support regimens. Reprod. Fertil Dev. 1990, 2(4):351-358.
59. Akuailou, P.Vijayagopal, V.Imrhan, C.Prasad E.-N. Measurement and validation of the nature of salivary adiponectin. Acta Diabetol. 2012, 15(1):110-114.
60. Oskis, A.Clow, L.Thorn, C.Loveday, F.Hucklebridge A. Diurnal patterns of salivary cortisol and DHEA in adolescent anorexia nervosa. Stress 2012, 15(6):601-607.
61. Momtaz H., et al. Study of Helicobacter pylori genotype status in saliva, dental plaques, stool and gastric biopsy samples. World J. Gastroenterol. 2012, 18(17):2105-2111.
62. Szczeklik K., Owczarek D., Pytko-Polończyk J., Kesek B., Mach T.H. Proinflammatory cytokines in the saliva of patients with active and non-active Crohn's disease. Pol. Arch. Med. Wewn. 2012, April 24. (pii: AOP79).
63. Plosa E.J., et al. Cytomegalovirus infection. Pediatr. Rev. 2012, 33(4):156-163. (quiz 163).
64. Turner D.O., et al. High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health 2011, 11:28.
65. Dantzer R., Kalin N. Psychoneuroendocrinology 2009, 34(1).
66. Shirtcliff E.A., Granger D.A., Schwartz E., Curran M.J. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 2001, 26(2):165-173.
67. Nokes D.J., et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull. World Health Org. 2001, 79(7):588-595.
68. Agha-Hosseini F., et al. Relationship of stimulated saliva 17beta-estradiol and oral dryness feeling in menopause. Maturitas 2009, 62(2):197-199.
69. McMurray D.N., et al. Effect of moderate malnutrition on concentrations of immunoglobulins and enzymes in tears and saliva of young Colombian children. Am. J. Clin. Nutr. 1977, 30(12):1944-1948.
70. Hovi T., Stenvik M. Selective isolation of poliovirus in recombinant murine cell line expressing the human poliovirus receptor gene. J. Clin. Microbiol. 1994, 32(5):1366-1368.
71. Hobson R.S. Challenges to future dental education. Br. Dent. J. 2009, 206(3):125-126.
72. Howard V.J., et al. Does sex matter? Thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) lead-in phase. Stroke 2009, 40(4):1140-1147.
73. Fischer H.P., Eich W., Russell I.J. A Possible Role for Saliva as a Diagnostic Fluid in Patients with Chronic Pain 1998, Elsevier, Seminars in Arthritis and Rheumatism 26 (6), 348-359.
74. Neville V., Gleeson M., Folland J.P. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Med. Sci. Sports Exercise 2008, 40(7):1228.
75. Swinkels L.M., et al. Concentrations of total and free dehydroepiandrosterone in plasma and dehydroepiandrosterone in saliva of normal and hirsute women under basal conditions and during administration of dexamethasone/synthetic corticotropin. Clin. Chem. 1990, 36(12):2042-2046.
76. Worthman C.M., Stallings J.F., Hofman L.F. Sensitive salivary estradiol assay for monitoring ovarian function. Clin. Chem. 1990, 36(10):1769-1773.
77. Latchaw R.E., et al. Recommendations for imaging of acute ischemic stroke: a scientific statement from the American Heart Association. Stroke 2009, 40(11):3646-3678.
78. Harris G.P., et al. Three distinct amine receptors operating at different levels within the locomotory circuit are each essential for the serotonergic modulation of chemosensation in Caenorhabditis elegans. J. Neurosci. 2009, 29(5):1446-1456.
79. Hobson R.P., et al. How mothers with borderline personality disorder relate to their year-old infants. Br. J. Psychiatry 2009, 195(4):325-330.
80. Nsutebu E.F., Hobson R. Is combination systemic therapy superior to monotherapy for enterococcal prosthetic joint infection?. Clin. Infect. Dis. 2009, 48(4):495. (author reply 495-6).
81. Schulz B.L., Cooper-White J., Punyadeera C.K. Saliva proteome research: current status and future outlook. Crit. Rev. Biotechnol. 2012.
82. Huang C.-M. Comparative proteomic analysis of human whole saliva. Arch. Oral Biol. 2004, 49(12):951-962.
83. Dawes C. Considerations in the development of diagnostic-tests on saliva. Ann. N.Y. Acad. Sci. 1993, 694:265-269.
84. Whiteaker J.R., et al. A targeted proteomics-based pipeline for verification of biomarkers in plasma. Nat. Biotechnol. 2011, 29(7):625-634.
85. St John M.A., et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2004, 130(8):929-935.
86. Ghezzi E.M., Ship J.A. Aging and secretory reserve capacity of major salivary glands. J. Dent. Res. 2003, 82(10):844-848.
87. Westermark A., et al. Basic fibroblast growth factor in human saliva decreases with aging. Laryngoscope 2002, 112(5):887-889.
88. Navazesh M., Kumar S.K.S. Measuring salivary flow: challenges and opportunities. J. Am. Dent. Assoc. 2008, 139(Suppl. 2):35S-40S.
89. Carlson A.J., Crittenden A.L. The relation of ptyalin concentration to the diet and to the rate of secretion of the saliva. Am. J. Physiol. 1910, 26(1):169-177. (Legacy Content).
90. Heft M.W., Baum B.J. Basic biological sciences unstimulated and stimulated parotid salivary flow rate in individuals of different ages. J. Dent. Res. 1984, 63(10):1182-1185.
91. Mohamed, J.-L. Campbell, J. Cooper-White, G. Dimeski, C. Punyadeera, The impact of saliva collection and processing methods on CRP, IgE, and myoglobin immunoassays, J. Clin. Trans. Med. September, 5, (2012).
92. Chomdej S., et al. Detection of SNPs and linkage and radiation hybrid mapping of the porcine C-reactive protein (CRP) gene. Anim. Genet. 2004, 35(6):469-470.
93. Du Clos T.W. Function of C-reactive protein. Ann. Med. 2000, 32(4):274-278.
94. Black S., Kushner I., Samols D. C-reactive protein. J. Biol. Chem. 2004, 279(47):48487-48490.
95. Sankaranarayanan R., et al. An overview of cancer survival in developing countries. IARC Sci. Publ. 1998, (145):135-173.
96. Forastiere A., et al. Head and neck cancer. N. Engl. J. Med. 2001, 345(26):1890-1900.
97. Turner D., et al. High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health 2011, 11(1):28.
98. Goon P., et al. HPV & head and neck cancer: a descriptive update. Head Neck Oncol. 2009, 1(1):36.
99. Li Y., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin. Cancer Res. 2004, 10(24):8442-8450.
100. Guerrero-Preson R., et al. Global DNA methylation: a common early event in oral cancer cases with exposure to environmental carcinogens or viral agents. P. R. Health Sci. J. 2009, 28(1):24-29.
101. Das P.M., Singal R. DNA methylation and cancer. J. Clin. Oncol. 2004, 22(22):4632-4642.
102. Chandra Mouli P.E., Manoj Kumar S., Parthiban S. Nanotechnology in dentistry-a review. Int. J. Biol. Med. Res. 2012, 3(2):1550-1553.
103. Freitas R. Nanodentistry. J. Am. Dent. Assoc. 2000, 131(11):1559-1563.
104. Li Y., Denny P., Ho C.M. The oral fluid MEMS/NEMS Chip (OFMNC): diagnostic and translational applications. Adv. Dent. Res. 2005, 18:3-5.
105. Sundaram M. Nanodentistry: a step ahead. JIDAT 2012, 4:23-26.
106. Gau V., Wong D. Oral fluid nanosensor test (OFNASET) with advanced electrochemical-based molecular analysis platform. Ann. N.Y. Acad. Sci. 2007, 1098:401-410.